U.S. Home Infusion Therapy Market (By Product: Infusion Pumps, Needleless Connectors; By Application: Anti-Infective, Endocrinology) - Industry Analysis, Size, Share, Growth, Trends, Revenue, Regional Outlook and Forecast 2022-2030

The U.S. home infusion therapy market size was estimated at around USD 16.6 billion in 2021 and it is projected to hit around USD 31.93 billion by 2030, growing at a CAGR of 7.54% from 2022 to 2030.

Report Highlights

• The infusion pumps segment held the largest revenue share of 50.84% in 2021. 
• The anti-infective segment registered a significant revenue share of 27.31% in 2021. 

The growing geriatric population and increasing prevalence of disorders, such as cancer, immune deficiencies, Crohn's disease, infections, dehydration, nutritional deficiencies, multiple sclerosis, nausea, and vomiting are majorly driving the market’s growth. The increasing need for reduced hospital stays and the rising prevalence of chronic disorders in the geriatric population are driving the growth.

Growing cases of Hospital Acquired Infections (HAI) is another major factor driving the growth of the U.S. home infusion therapy industry over the forecast period. According to the U.S. Centers for Disease Control and Prevention, approximately 1.7 million admitted patients are affected annually by Healthcare Acquired infections (HCAIs) and around 98, 000 patients (1 in 17 patients) die due to the same. Due to this, the demand for home infusion therapy is increasing substantially.

Increasing innovations in home infusion therapy such as the incorporation of electronic healthcare records along with medical devices and infusion pumps are trending. It allows storage, retrieval, and alteration of medical records, making it easier for healthcare professionals and patients to track the improvements in a particular disorder.

Increasing patients’ preference for home healthcare since it is cost-efficient in comparison with hospital stays is an opportunity for the industry players to launch more innovative products. Also, the introduction of safety products will ultimately help the growth of the U.S. home infusion therapy market. The advent of COVID-19 boosted the home infusion market in the country as many key players like Baxter, BD, ICU Medical, and Option Care Health, Inc reported revenue increases for their home infusion products and services in 2020 and 2021. This trend is expected to further boost the market as numerous healthcare settings in the country are expected to permanently opt for home infusion services to decrease patient admission burden in hospitals and other healthcare facilities

Scope of The Report

Product Insights

The infusion pumps segment held the largest revenue share of 50.84% in 2021. The infusion pumps segment is further categorized into ambulatory infusion pumps, elastomeric pumps, syringe pumps, insulin pumps, Patient Controlled Analgesics (PCA), and volumetric pumps. This can be attributed to their increasing use and efficiency in delivering nutrition, medications, and other required fluids in required amounts. In addition, modernized infusion pumps are equipped with alert systems to avoid the risk of adverse drug interaction or when the pump parameters are indifferently set. These factors are expected to drive segment growth.

The needleless connectors segment is expected to be the fastest-growing owing to various benefits, such as less risk of bacterial contamination and higher protection against needlestick injuries. Moreover, needleless connectors reduce the risk of Health-care Associated Bloodstream Infections (HA-BSIs). Owing to these features, the demand for needleless connectors is predicted to augment over the forecast period.

Application Insights

The anti-infective segment registered a significant revenue share of 27.31% in 2021. The significant share of the segment is attributed to its extensive use as an antifungal, antibiotic, and antiviral agent at-home care. Moreover, growing efforts for reducing hospital stays are also increasing the demand for anti-infective therapy, thereby driving the segment’s growth. By application, the market is divided into anti-infective, endocrinology, hydration therapy, parenteral nutrition, enteral nutrition, chemotherapy, specialty pharmaceuticals, and others.

Endocrinology is predicted to be the fastest-growing segment owing to the growing number of conditions associated with the endocrine system. The thyroid is one of the most common disorders prevalent in the U.S., sometimes resulting in death. According to the American Cancer Society, 2019, approximately 52,070 thyroid cancer cases have been registered (14,260 in males and 37,810 in females). Hence, growing cases of thyroid along with metabolic disorders in the U.S. is expected to drive the segment.

Regional Insights

Owing to the increasing number of chronic disorders prevalent in individuals and growing initiatives by the government for the advantages of home infusion therapy, the industry is expected to grow considerably. Moreover, increasing demand for long-term therapies by patients is also expected to fuel the growth in the near future.

Major factors driving the growth include an increase in the geriatric population and a rise in disease burden. In addition, growing awareness has led to a higher inclination of patients, especially the geriatric population, to require long-term care toward home infusion therapy. It has been estimated that the administration of medications at home costs from USD 150 to USD 200 per day, much lesser than the cost of a typical inpatient stay, which costs from USD 1,500 to USD 2,500 per day.

The well-established healthcare industry, easy access to healthcare needs, faster adoption of advanced technologies, and high disposable income of consumers are a few other drivers of the U.S. home infusion therapy market. The availability of superior-quality home infusion products to patients is also propelling the industry.

Key Players

• B. Braun Melsungen,
• Baxter International,
• Caesarea Medical Electronics Ltd.,
• CareFusion,
• Fresenius Kabi,
• ICU Medical,
• JMS CO., LTD.,
• Smiths Medical, Inc.,
• Terumo Corporation,
• Coram LLC,
• Option Care Enterprises, Inc.,
• BioScrip, Inc.,
• BriovaRx Infusion Services,
• Paragon Healthcare.

Market Segmentation

• By Product Outlook
• Infusion pumps

• Elastomeric

• Electromechanical

• Gravity

• Others

• Intravenous Sets
• IV Cannulas
• Needleless Connectors
• By Application Outlook
• Anti-Infective
• Endocrinology

• Diabetes

• Others

• Hydration Therapy

• Athletes

• Others

• Chemotherapy
• Enteral Nutrition
• Parenteral Nutrition
• Specialty Pharmaceuticals
• Others